Investor Relations LatestPress Releases May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Apr 11, 2024 Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference btn News IR View All RecentEvents Apr 10, 2024 10 Apr 2024 at 8:30 AM EDT First-Quarter Fiscal 2024 Financial Results Conference Call Listen to Webcast Feb 21, 2024 21 Feb 2024 at 8:30 AM EST Fourth-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast Sep 26, 2023 26 Sep 2023 at 8:30 AM EDT Third-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast btn Events View All Financial InformationLatest Earnings Show all Q1 2024 Financial Statement 501.2 KB MD&A 399.2 KB btn QRs View More PresentationsInvestor Presentation Download PDF
May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Apr 11, 2024 Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Apr 10, 2024 10 Apr 2024 at 8:30 AM EDT First-Quarter Fiscal 2024 Financial Results Conference Call Listen to Webcast
Feb 21, 2024 21 Feb 2024 at 8:30 AM EST Fourth-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast
Sep 26, 2023 26 Sep 2023 at 8:30 AM EDT Third-Quarter Fiscal 2023 Financial Results Conference Call Listen to Webcast